Date  |
|
| Jul 20, 2017 |
Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter |
| Jul 07, 2017 |
Wound Management Technologies Announces Publication of the Use of CellerateRX(R) Surgical Activated Collagen(R) on Surgical Incisions Following Cranial or Spinal Neurosurgery |
| May 17, 2017 |
Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director |
| Apr 27, 2017 |
Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies |
| Mar 08, 2017 |
Wound Management Technologies Announcements |
| Feb 14, 2017 |
Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 - Up 147% over Q4 2015, and 63% over 2015 |
| Dec 08, 2016 |
Wound Management Technologies Welcomes J. Michael Carmena as its New CFO |
| Nov 01, 2016 |
Wound Management Technologies Reports Preliminary Financial Results For Q3 2016 Sales Up 56% over Q3 2015, and 2016 YTD Sales Up 41% over 2015 YTD Sales |
| Aug 12, 2016 |
Q2 2016 Sales Up 69% over Q2 2015, and 2016 YTD Sales Up 34% over 2015 YTD Sales for Wound Management Technologies |
| May 16, 2016 |
Wound Management Technologies Reports Positive Net Income for Q1 Ended March 31, 2016 |